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Glutathione S-transferases (GSTs) are enzymes involved in the detoxification of several environmental 
mutagens, carcinogens and anticancer drugs. GST polymorphisms resulting in decreased enzymatic 
activity have been associated with several types of solid tumors. We determined the frequencies of the 
deletion of two GST subfamilies genes, M1 and T1, in patients with acute lymphocytic leukemia (ALL). 
Using polymerase chain reactions, we analyzed the GSTM1 and GSTT1 genotype in 135 patients with 
ALL (01-10 years) and 146 age matched controls. The prevalence of GSTM1 and GSTT1 homozygous 
resulting in null genotypes at the GSTM1 and GSTT1 loci were detected 60 (44.44%) and 48 (35.55%) 
patients, and 61 (41.75%) and 23 (15.75%) controls, respectively. The presence of at least one GST 
deletion proved to be an independent prognostic risk factor for response to treatment. In conclusion, 
individuals with GSTM1 or GSTT1 deletions (or deletions of both) may have an enhanced resistance to 
chemotherapy and a shorter survival.  
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INTRODUCTION 
           
Glutathione S-transferases (GSTs) are a family of 
cytosolic enzymes involved in the detoxification of various 
exogenous as well as endogenous reactive species. 
GSTs function as dimers by catalyzing the conjugation of 
mutagenic electrophilic substrates to glutathione which 
are water-soluble and can be excreted from the body. In 
humans, 4 major subfamilies of GSTs can be distin-
guished and are designated as GST,  GST, GSTu, and  
GSTpi. Each of these subfamilies is composed of several 
members, some of which display genetic polymorphism. 
Within the GSTµ subfamily, the gene coding for GSTM1 
exhibits a deletion polymorphism, which in case of 
homozygozity (GST M1 null) leads to absence of 
phenotypic enzyme activity. A similar mecha-nism is 
described for GST T1 within the GSTu  subfamily, where- 
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as the gene coding for GST P1, a member of the GSTp 
subfamily, displays polymorphisms within its coding 
region at codon 105 (Ile105Val). The coding region 
polymorphisms within GST P1 have been suggested to 
confer different catalytic activities. 
Previous studies have shown that hereditary 
differences in specific GST enzyme activities are due to 
genetic polymorphisms (Pembleetal, 1994; Harada et al., 
1992). The absence of GST M1 activity is caused by 
inheritance of two null alleles (alleles that have a deletion 
of GST M1 gene) (Harada et al., 1992). Similarly, 
individuals with no GST T1 activity also have inherited 
null alleles of GST T1 gene (Pemble et al., 1994). 
Several studies have shown that the null genotypes of 
GST M1 (Harada et al., 1992; Seidegard et al., 1990; 
Saadat et al., 2000) and GST T1 (Pemble et al., 1994) 
predispose to the development of specific types of 
cancers. Important environmental  carcinogens (e.g. ben- 
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Table 1. Distribution of GST M1 and GST T1 null genotypes in ALL cases and controls. 
 
 Genotype Patients (%) n = 135 Controls (%) n =146 OR (95% CI) χ2 p- value 
GST M1 
H/H 75 (55.55) 88 (60.27) 1.00  (NA) NA NA 
Null 60 (44.44) 61 (41.75) 0.87  (0.53-1.43) 0.36 0.55 
GST T1 
H/H 87 (64.44) 123 (84.24) 1.00  (NA) NA NA 
Null 48 (35.55) 23 (15.75) 0.34 (0.18-0.62) 14.5 0.00013 
 
OR, crude odds ratios; CI, confidence interval with 95% of probability; NA, not applicable. 
 
 
 
zo[a]pyrene and other polyaromatic hydrocarbons) are 
detoxified through the GST system. Inter-individual 
differences in GST enzyme activity mediated by 
polymorphic genes have been suggested to confer 
varying susceptibility to environmental cancer.  However, 
in contrast to the role of GSTs in environmental 
carcinogenesis, GST genotypes conferring lower enzyme 
activity may be of advantage for individuals undergoing 
chemotherapeutic treatment for neoplastic disease 
because reduced detoxification potentially enhances 
effectiveness of cytotoxic drugs (Willett et al., 1989).  
The major objective of this study is to assess the role of 
GSTs and childhood acute lymphocytic leukemia (ALL). 
Secondly, we aim to determine the gene frequency of 
these two genetic polymorphisms (GST M1 and GST T1) 
and to assess their roles in relation to its susceptibility to 
childhood cancers. In order to get a better insight into the 
association between the null genotypes of GST M1 and 
GST T1 and susceptibility to ALL, the frequencies of GST 
M1, and GST T1 null genotypes among Indian pediatrric 
ALL patients were determined and compared with those 
of healthy control group.  
 
 
MATERIAL AND METHODS 
 
Study group and sample collection 
 
The study group consisted of 135 individuals diagnosed with acute 
lymphocytic leukemia from various cancer hospitals in the city of 
Hyderabad, AP (India). Cases were children aged 1-10 years who 
were diagnosed with acute lymphocytic leukemia between 
September 2003 and May, 2005. Patients were approached, with 
the physician's and ethical committee clearance. The procedures 
followed were in accordance with the ethical standards of 
responsible committee of the Institutes/Hospitals, to participate in a 
face-to-face interview using a structured questionnaire. For each 
participating case, one control was selected randomly from a list of 
children registered with the same local institutes who were of the 
same sex, year of birth (±2 years), and the study group was of 
Indian origin and particular region i.e.  Andhra Pradesh, India. 
Cases diagnosed with acute lymphocytic leukemia within 6 months 
of being diagnosed with a prior hematological malignancy or within 
one year of any other cancer were considered ineligible. This 
criterion also was applied to the corresponding controls of cases 
(pseudo diagnosis being taken as the date of case diagnosis). 
135 cases were acute lymphocytic leukemia (ALL) with 
142 individually matched controls  and a mean age of 4.2 years.  
Genotyping analysis 
 
Blood samples were obtained from patient and control groups. 
Immediately after collection, genomic DNA was extraction and used 
for polymerase chain reaction (PCR). The PCR conditions for 
determining GST M1 and GST T1 genotypes were the same as 
those reported previously (Pemble etal., 1994; Harada et al., 1992; 
Stella et al., 2002). For evaluating GST M1 and GST T1 
polymorphisms the amplification products were analyzed by gel 
electrophoresis (1.6% agarose). To test for contamination, negative 
controls (tubes containing the PCR mixture without the DNA 
template) were included in every run. A 1,030 bp fragment was 
amplified by PCR with the GST M1 primers while a 480 bp fragment 
was amplified with the GST T1 primers. The absence of an 
amplified product was consistent with the null genotypes. 
Successful amplification by -globin-specific primers confirmed the 
proper function of the PCR reaction. 
 
 
Statistical analysis 
 
The association between GST M1 and GST T1 genotypes and the 
development of Acute Lymphocytic Leukemia was examined by using 
odds ratio (OR) and 95% confidence intervals (CI) derived from 
logistic regression analysis using EPI6 software (Epiinfo6 CDC). 
Because GST M1 and GST T1 genotypes may interact with each 
other in the development of ALL, further analysis combining the 
GST M1 and GST T1 genotypes was carried out. 
 
 
RESULTS AND DISCUSSION 
 
Both GST T1 and GST M1 were screened for individual 
genotypic characters assessed. These results of cases 
and control studies are presented in Table 1. The 
frequencies of GST M1 and GST T1 variants are 
presented in Yates corrected Chi-square and p-values. 
The frequency of the cases and controls in the total 
population of GST M1 and GST T1 homozygous were 
determined. Null genotypes at the GST M1 and GST T1 
loci were detected in 60 (44.44%) and 48 (35.55%) 
patients and in controls 61 (41.75%) and 23 (15.75%), 
respectively. 
Our results showed that there was weak association of 
GSTs and risk of childhood ALL in the population (Table 
1). However, patients with the double gene deletions of 
GST T1 and GST M1 showed improve treatment out-
come. There were 20% of the relapsed patients that have 
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double gene deletions. This suggests that GST M1 and 
GST T1 genes do play a role in regulating the 
effectiveness of cancer-treatment drugs. This preliminary 
study have shown that GSTs play a significant role in the 
treatment of childhood ALL. However, the data is too 
small for adequate analysis. The function of GSTs 
enzymes is mainly detoxification of xenobiotics. It may 
also be interesting to look at GSTs and treatment toxicity 
in childhood ALL, although the reverse is true that the 
absence of GSTs improve treatment outcome. 
In conclusion, our study shows that the double gene 
deletions is associated with improved treatment outcome 
for childhood ALL and knowing a patient’s genotype for 
GST allows oncologists to better tailor therapy for 
children with ALL. There is weak correlation between the 
GSTs and susceptibility in childhood ALL. Our data 
demonstrated that, although the GST M1 and GST T1 
null genotypes are more frequent in ALL cases than in 
control subjects, these differences are not of statistical 
significance (Table 1). Since different GST isoenzymes 
are known to exhibit overlapping substrate specificities, 
deficiencies of GST isoenzymes may be compensated by 
other isoforms and utilization of alternative metabolic 
pathways (Mannervi et al., 1988; Hates et al., 1995). It is, 
therefore, anticipated to be important to determine more 
than one genotype to obtain a reliable picture of the 
potential role of metabolic polymorphisms in individual 
responses to environmental toxicants. 
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